Table 1.
Patient Characteristics | Mean ± Standard Deviation (Extremes) or n (%) (N = 200) |
---|---|
Age at diagnosis (years) | 62.72 ± 9.19 (27–83) |
BMI (kg/m2) | 27.90 ± 6.31 (15.43–50.17) |
Score ASA 3 | |
1 | 15 (7.50) |
2 | 15 (7.50) |
3 | 14 (7.00) |
NR 1 | 72 (36.00) |
Initial histological type | |
Endometrioid | 96 (48.00) |
Clear cells | 16 (8.00) |
Papillary serous | 44 (22.00) |
Carcinosarcoma | 26 (13.00) |
Poorly differentiated | 16 (8.00) |
In situ | 1 (0.50) |
Hyperplasia with atypia | 1 (0.50) |
Initial grade | |
1 | 25 (12.50) |
2 | 48 (24.00) |
3 | 108 (54.00) |
NR | 19 (9.50) |
Initial stage 2 | |
IA | 37 (18.50) |
IB | 34 (17.00) |
II | 15 (7.50) |
IIIA | 10 (5.00) |
IIIB | 3 (1.50) |
IIIC1 | 37 (18.50) |
IIIC2 | 59 (29.50) |
IVA | 2 (1.00) |
IVB | 3 (1.50) |
Initial indication for PAL 4 | |
At diagnosis | 149 (74.50) |
After hysterectomy results | 42 (21.00) |
After positive pelvic lymph node finding | 9 (4.50) |
1 NR: not reported, 2 Stage evaluated by MRI and/or FDG-PET/CT, 3 ASA: American Society of Anesthesiologists, 4 PAL: Para-Aortic Lymphadenectomy.